243 related articles for article (PubMed ID: 22582048)
1. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Jun; 53(6):928-38. PubMed ID: 22582048
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
4. [Magnetic resonance in oncology].
Terrier F; Schuknecht B; Fretz C; Vock P; Herschkowitz N
Schweiz Med Wochenschr; 1990 Sep; 120(35):1257-72. PubMed ID: 2218448
[TBL] [Abstract][Full Text] [Related]
5. Whole-body MRI for the staging and follow-up of patients with metastasis.
Schmidt GP; Reiser MF; Baur-Melnyk A
Eur J Radiol; 2009 Jun; 70(3):393-400. PubMed ID: 19457631
[TBL] [Abstract][Full Text] [Related]
6. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
7. Nuclear magnetic resonance imaging in oncology.
Frank JA; Dwyer AJ; Doppman JL
Important Adv Oncol; 1987; ():133-74. PubMed ID: 3331379
[TBL] [Abstract][Full Text] [Related]
8. Nodal staging of rectal cancer: high-resolution pelvic MRI versus ¹⁸F-FDGPET/CT.
Kim DJ; Kim JH; Ryu YH; Jeon TJ; Yu JS; Chung JJ
J Comput Assist Tomogr; 2011; 35(5):531-4. PubMed ID: 21926843
[TBL] [Abstract][Full Text] [Related]
9. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
10. Comparison of magnetic resonance imaging-fluorodeoxy- glucose positron emission tomography fusion with pathological staging in rectal cancer.
Kam MH; Wong DC; Siu S; Stevenson AR; Lai J; Phillips GE
Br J Surg; 2010 Feb; 97(2):266-8. PubMed ID: 20035542
[TBL] [Abstract][Full Text] [Related]
11. Image-guided percutaneous needle biopsy in cancer diagnosis and staging.
Gupta S; Madoff DC
Tech Vasc Interv Radiol; 2007 Jun; 10(2):88-101. PubMed ID: 18070687
[TBL] [Abstract][Full Text] [Related]
12. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
13. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
14. Oncologic PET/MRI, part 2: bone tumors, soft-tissue tumors, melanoma, and lymphoma.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Aug; 53(8):1244-52. PubMed ID: 22782313
[TBL] [Abstract][Full Text] [Related]
15. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
16. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: evaluation with PET/CT data.
Martinez-Möller A; Souvatzoglou M; Delso G; Bundschuh RA; Chefd'hotel C; Ziegler SI; Navab N; Schwaiger M; Nekolla SG
J Nucl Med; 2009 Apr; 50(4):520-6. PubMed ID: 19289430
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of PET/CT is similar to that of conventional MRI and even better for detecting small peritoneal implants in patients with recurrent ovarian cancer.
Sanli Y; Turkmen C; Bakir B; Iyibozkurt C; Ozel S; Has D; Yilmaz E; Topuz S; Yavuz E; Unal SN; Mudun A
Nucl Med Commun; 2012 May; 33(5):509-15. PubMed ID: 22357440
[TBL] [Abstract][Full Text] [Related]
18. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen.
Kuehl H; Veit P; Rosenbaum SJ; Bockisch A; Antoch G
J Nucl Med; 2007 Jan; 48 Suppl 1():45S-57S. PubMed ID: 17204720
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of the chest, abdomen, and pelvis in the evaluation of pregnant patients with neoplasms.
Oto A; Ernst R; Jesse MK; Chaljub G; Saade G
Am J Perinatol; 2007 Apr; 24(4):243-50. PubMed ID: 17447186
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography/magnetic resonance imaging evaluation of lung cancer: current status and future prospects.
Yoon SH; Goo JM; Lee SM; Park CM; Seo HJ; Cheon GJ
J Thorac Imaging; 2014 Jan; 29(1):4-16. PubMed ID: 24296699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]